Differential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary Management

Gestational diabetes mellitus (GDM) affects placental metabolism, influencing both maternal and fetal outcomes. This study investigated the expression of metabolic regulators—Pyruvate Kinase M2 (PKM2), AMP-activated protein kinase (AMPK), and mTOR pathway components—in placental tissues from GDM pre...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily Broberg, Jillise English, Derek M. Clarke, Marley J. Shin, Benjamin T. Bikman, Paul R. Reynolds, Juan A. Arroyo
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/6/416
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342932451065856
author Emily Broberg
Jillise English
Derek M. Clarke
Marley J. Shin
Benjamin T. Bikman
Paul R. Reynolds
Juan A. Arroyo
author_facet Emily Broberg
Jillise English
Derek M. Clarke
Marley J. Shin
Benjamin T. Bikman
Paul R. Reynolds
Juan A. Arroyo
author_sort Emily Broberg
collection DOAJ
description Gestational diabetes mellitus (GDM) affects placental metabolism, influencing both maternal and fetal outcomes. This study investigated the expression of metabolic regulators—Pyruvate Kinase M2 (PKM2), AMP-activated protein kinase (AMPK), and mTOR pathway components—in placental tissues from GDM pregnancies managed with either insulin (GDM-I) or dietary interventions (GDM-D). We hypothesize that metabolic adaptation in GDM is differentially regulated by treatment modality. This study analyzed 30 cases, including 10 control pregnancies,10 GDM-D cases, and 10 GDM-I cases. Analytical methods included immunofluorescence and immunoblotting. We observed an upregulation of PKM2 in both GDM-I and GDM-D placentas, suggesting enhanced glycolytic adaptation under GDM-induced metabolic stress. AMPK expression was significantly elevated in GDM-I and moderately increased in GDM-D placentas, potentially compensating for insulin resistance by promoting glucose uptake and energy homeostasis. Furthermore, mTOR pathway activation differed by treatment type, suggesting a treatment-specific mTOR response. The metabolic changes observed suggest that treatment modality in GDM may have direct implications for maternal and fetal health. Our findings indicate that while insulin and dietary management support metabolic adaptation in GDM, they do so through distinct mechanisms. These findings support a personalized approach in GDM treatment, where patient-specific metabolic responses should guide therapeutic decisions.
format Article
id doaj-art-c06ff1f4e4c54f67bd7e554093009cf6
institution Kabale University
issn 2073-4409
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-c06ff1f4e4c54f67bd7e554093009cf62025-08-20T03:43:11ZengMDPI AGCells2073-44092025-03-0114641610.3390/cells14060416Differential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary ManagementEmily Broberg0Jillise English1Derek M. Clarke2Marley J. Shin3Benjamin T. Bikman4Paul R. Reynolds5Juan A. Arroyo6Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USADepartment of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USADepartment of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USADepartment of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USADepartment of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USADepartment of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USADepartment of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USAGestational diabetes mellitus (GDM) affects placental metabolism, influencing both maternal and fetal outcomes. This study investigated the expression of metabolic regulators—Pyruvate Kinase M2 (PKM2), AMP-activated protein kinase (AMPK), and mTOR pathway components—in placental tissues from GDM pregnancies managed with either insulin (GDM-I) or dietary interventions (GDM-D). We hypothesize that metabolic adaptation in GDM is differentially regulated by treatment modality. This study analyzed 30 cases, including 10 control pregnancies,10 GDM-D cases, and 10 GDM-I cases. Analytical methods included immunofluorescence and immunoblotting. We observed an upregulation of PKM2 in both GDM-I and GDM-D placentas, suggesting enhanced glycolytic adaptation under GDM-induced metabolic stress. AMPK expression was significantly elevated in GDM-I and moderately increased in GDM-D placentas, potentially compensating for insulin resistance by promoting glucose uptake and energy homeostasis. Furthermore, mTOR pathway activation differed by treatment type, suggesting a treatment-specific mTOR response. The metabolic changes observed suggest that treatment modality in GDM may have direct implications for maternal and fetal health. Our findings indicate that while insulin and dietary management support metabolic adaptation in GDM, they do so through distinct mechanisms. These findings support a personalized approach in GDM treatment, where patient-specific metabolic responses should guide therapeutic decisions.https://www.mdpi.com/2073-4409/14/6/416GDMplacental metabolismPKM2AMPKmTOR
spellingShingle Emily Broberg
Jillise English
Derek M. Clarke
Marley J. Shin
Benjamin T. Bikman
Paul R. Reynolds
Juan A. Arroyo
Differential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary Management
Cells
GDM
placental metabolism
PKM2
AMPK
mTOR
title Differential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary Management
title_full Differential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary Management
title_fullStr Differential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary Management
title_full_unstemmed Differential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary Management
title_short Differential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary Management
title_sort differential regulation of pkm2 ampk and mtor in response to insulin and dietary management
topic GDM
placental metabolism
PKM2
AMPK
mTOR
url https://www.mdpi.com/2073-4409/14/6/416
work_keys_str_mv AT emilybroberg differentialregulationofpkm2ampkandmtorinresponsetoinsulinanddietarymanagement
AT jilliseenglish differentialregulationofpkm2ampkandmtorinresponsetoinsulinanddietarymanagement
AT derekmclarke differentialregulationofpkm2ampkandmtorinresponsetoinsulinanddietarymanagement
AT marleyjshin differentialregulationofpkm2ampkandmtorinresponsetoinsulinanddietarymanagement
AT benjamintbikman differentialregulationofpkm2ampkandmtorinresponsetoinsulinanddietarymanagement
AT paulrreynolds differentialregulationofpkm2ampkandmtorinresponsetoinsulinanddietarymanagement
AT juanaarroyo differentialregulationofpkm2ampkandmtorinresponsetoinsulinanddietarymanagement